Liver Cancer Trial, Recruiting NCT01479608 Sponsor: Oslo University Hospital Condition: Liver Cancer
Back to Liver Cancer

Liver Cancer Trial, Recruiting

NCT01479608
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with bowel cancer (colon or rectal cancer) that has been confirmed by a tissue sample (biopsy).
  • Scans (PET/CT and CT or MRI of the chest, abdomen, and pelvis) show the cancer has not spread outside the liver, and there is no sign of the original cancer coming back.
  • A camera examination or scan of the bowel within the last 12 months shows no signs of the cancer returning at the original site.
  • You are generally well and able to carry out daily activities with little or no limitation (confirm with trial site what this means for you).
  • Your blood test results meet certain levels for red blood cells, white blood cells, platelets, liver function, kidney function, and protein levels (confirm specific values with trial site).
  • If you had rectal cancer, your surgery removed the cancer with a safe margin of healthy tissue around it.
  • You have given written agreement to take part and are willing to attend follow-up appointments.
  • You have already received at least 3 cycles (about 6 weeks) of chemotherapy, and your cancer has not grown during that treatment.

Additional criteria depending on which part of the trial you may join:

  • Part A: You have six or more liver tumours that could technically be removed by surgery.
  • Part B: Your liver tumours appeared more than 12 months after your bowel cancer diagnosis and/or after finishing any earlier preventative chemotherapy; your original bowel cancer had not spread to nearby lymph nodes; a specific blood marker (CEA) was below a certain level at diagnosis and when the liver tumours were found; your liver tumours cannot be fully removed by surgery; before starting your first round of chemotherapy, no single tumour was larger than 10 cm and you had 20 or fewer tumours in total; and your tumours shrank by at least 10% with your first chemotherapy.
  • Part C: Your liver tumours cannot be fully removed by surgery; you have already had one course of chemotherapy; before starting your second or third course of chemotherapy, no single tumour was larger than 10 cm and you had 20 or fewer tumours in total; your tumours shrank by at least 10% on your second or third chemotherapy; and it has been at least two years since your original bowel cancer diagnosis and the date you were added to the transplant waiting list.
  • Part D: Without a liver transplant, your doctors expect you may have around 6 to 12 months to live; you may be included without needing further chemotherapy first; and you may have lung tumours that could potentially be removed by surgery.

Who may not be able to join:

  • You have lost more than 10% of your body weight in the last 6 months.
  • Your Body Mass Index (BMI) is over 30 (confirm with trial site).
  • You have or have had another type of cancer.
  • Your cancer has previously spread to areas outside the liver, or the original bowel cancer has previously come back.
  • You did not receive the standard recommended treatments before, during, or after your original bowel cancer surgery.
  • Your original bowel cancer surgery was carried out only to relieve symptoms, rather than to attempt a cure.
  • You have already taken part in this trial before.
  • The trial doctor has any other concern about whether it is appropriate for you to participate.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 23026600

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
11 April 2012
Est. completion
1 December 2025

Where this trial is recruiting

🇳🇴 Norway

Primary endpoints

Overall survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov